This promotional session is organised and funded by Recordati Pharmaceuticals Limited.   Moudy Khodadi has received a speaker honorarium from Recordati for this presentation.

UK-VAZK-0145 | Date of prep: April 2026

Beyond LDL: the evidence for a broader approach to lipid management and reducing cardiovascular risk. Drawing on his experience running a Primary Care CVRM Clinic, Moudy will show how to maximise every consultation and optimise medication to lower residual CV risk in secondary prevention. He will use a simple flow to show you how to segment, treat, and incorporate newer agents into your approach for secondary prevention risk management.